Scilex Holding Co

Scilex Holding Company (Nasdaq: SCLX) is a specialty pharmaceutical company focused on non-opioid pain management products that completed its public debut through a SPAC merger with Vickers Vantage Corp. I, sponsored by Vickers Financial Group, in 2022. The company filed a DEFA14A — additional definitive proxy soliciting materials — with the SEC on May 5, 2026, indicating an active shareholder proxy process is underway. SCLX trades on Nasdaq and operates within the specialty pharmaceuticals sector, with a product portfolio targeting localized pain relief. Sign up at SpacDesk for full filing history, proxy analytics, and comprehensive SPAC deal data on SCLX and thousands of other transactions.